Skip to main content

Advertisement

Springer Nature Link
Log in

UHPLC Study on the Degradation Profiles of Olopatadine Hydrochloride in Eye Drops Subjected to Heat and Filtration Methods of Sterilisation

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A validated ultra-high performance liquid chromatography (UHPLC) method has been proposed, validated and used for the determination of olopatadine hydrochloride degradation products in olopatadine 1 mg mL−1 eye drops solution under the influence of two different sterilisation methods, heating and filtration, with good precision and accuracy. We found that the heat sterilization method yields a higher content of olopatadine hydrochloride degradation products in eye drops compared to unsterilized drug product or drug product sterilized by filtration, except for α-hydroxy olopatadine impurity, which remains stable with time and applied sterilization method. Contents of olopatadine related compound B shows a higher increase (from <0.005 to 0.044 %) when sterilised by heating than when subjected to aging and sterilization by filtration (increase up to 0.011 %). Similarly, total amount of all impurities is also increased from 0.13 to 0.49 % when the drug product is sterilised by heating instead of filtration (up to 0.39 %). Content of olopatadine related compound B and of all impurities is increased by aging, probably through thermal and oxidative degradation. Forced degradation studies were correlated with the sterilisation study and possible degradation pathways were identified. Olopatadine shows strong degradation under oxidative and moderate degradation under photolytic environment, with the olopatadine related compound B as the main degradation product. Sterilization of eye drops solution by filtration is recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Ohshima E, Sato H, Obase H, Uchimura T, Kuwabara T, Kobayashi S (1992) Chem Pharm Bull 40:2552–2554

    Article  CAS  Google Scholar 

  2. Rosenwasser LJ, O’Brien T, Weyne J (2005) Curr Med Res Opin 21:1377–1387

    Article  CAS  Google Scholar 

  3. Basniwal PK, Jain D (2013) J Anal Sci Technol 4:12

    Article  Google Scholar 

  4. Mahajana AA, Mohanrajb K, Kalec S, Thakera AK (2013) J Liq Chromatogr Relat Technol 36(13):1881–1898

    Google Scholar 

  5. Kumar RS, Ravi KBVV, Kumar PA, Neelakanta RN (2012) Asian J Res Chem 5(11):1395–1398

    Google Scholar 

  6. Rao NK, Ganapaty S, Lakshmana Rao A (2012) Int J Pharm Chem Biol Sci 2(4):712–717

    Google Scholar 

  7. Bhatt PD, Akhtar J (2011) Int J Pharm Sci Rev Res 9(2):153–158

    CAS  Google Scholar 

  8. Limbachiya UN, Patel NN, Nikesh R, Rajesh KS, Patel S, Shinde G (2013) Asian J Res Chem 6(4):389–392

    Google Scholar 

  9. Mahajan A, Gandhi P, Pandita N, Gandhi S, Deshpande P (2010) Int J ChemTech Res 2(3):1372–1375

    CAS  Google Scholar 

  10. Zhu P, Wen Y, Fan XP, Zhou ZL, Fan RX, Chen JM, Huang KL, Zhu XL, Chen YF, Zhuang J (2011) J Ana Toxicol 35:113–118

    Article  CAS  Google Scholar 

  11. Fujimaki K, Lee X-P, Kumazawa T, Sato J, Sato K (2006) Forensic Toxicol 24:8–16

    Article  CAS  Google Scholar 

  12. Mathrusri M, Hima G, Divya I (2012) Drug Invent Today 4(8):441–443

    Google Scholar 

  13. Dey S, Reddy YV, Swetha B, Kumar DS, Murthy PN, Sahoo SK, Kumar D, Patro SS, Mohapatra S (2010) Int J Pharm Pharm Sci 2(4):212–218

    CAS  Google Scholar 

  14. Bhatt YJ, Sharma SK, Multani PJ (2013) Int J Pharm Sci Rev Res 20(2):118–120

    CAS  Google Scholar 

  15. Varghese SJ, Kumar AM, Ravi TK (2011) J AOAC Int 94(6):1815–1820

    Article  CAS  Google Scholar 

  16. US Pharmacopoeia 34-NF 29 (2011) Official Monographs: Olopatadine Hydrochloride and Olopatadine Hydrochloride Ophthalmic solution, US Pharmacopeial Convention, Rockville, 3711–3713

  17. European Pharmacopoeia (2013) Conseil de l’Europe, Strasbourg, 01/2008:1163, 783

  18. Sy A, Srinivasan M, Mascarenhas J, Lalitha P, Rajaraman R et al (2012) Invest Ophthalmol Vis Sci 53:267–272

    Article  CAS  Google Scholar 

  19. European Pharmacopoeia (2013) Conseil de l’Europe, Strasbourg, 01/2008:50101, pp 555–556

  20. European Medicines Agency (2000) Decision trees for the selection of sterilisation methods (CPMP/QWP/054/98), European Union, London. http://www.ema.europa.eu. Accessed 18 Nov 2013

  21. European Medicines Agency (2006) Note for guidance on impurities in new drug products (CPMP/ICH/2738/99), European Union, London. http://www.ema.europa.eu. Accessed 18 Nov 2013

  22. ICH Q2 (R1) (2005) Harmonized tripartite guideline, Validation of analytical procedures: text and methodology, International Conference on Harmonization ICH, Geneva, 2005

  23. Center for Drug Evaluation and Research, US Food and Drug Administration (1994) Reviewer Guidance, Validation of Chromatographic Methods, FDA, Rockville, USA

  24. US Pharmacopoeia 36-NF 31 (2013) Physical Tests/ <621> Chromatography, US Pharmacopeial Convention, Rockville, pp 1–7

  25. ICH Q3 B (R2) (2006) Guidance for Industry Impurities in New Drug Products version 2, International Conference on Harmonization ICH, Geneva, 2006

  26. Ohshima E, Otaki S, Sato H, Kumazawa T, Obase H, Ishii A, Ishii H, Ohmori K, Hirayama N (1992) J Med Chem 35(11):2074–2084

    Article  CAS  Google Scholar 

  27. European Medicines Agency (2004) Scientific discussion for the approval of OPATANOL, European Union, London. http://www.ema.europa.eu. Accessed 21 Jan 2014

  28. Bobbitt JA, Betts RP (1992) J Microbiol Methods 16(3):215–220

    Article  Google Scholar 

Download references

Acknowledgments

We would like to express our gratitude to anonymous reviewers for carefully reading the manuscript and helping us to improve our work and presentation.

Author information

Authors and Affiliations

  1. Chromatographic Laboratory, Research and Development Department, JGL d.d. Rijeka, Svilno 20, 51000, Rijeka, Croatia

    L. Munjas Jurkic, M. Buratovic, I. Valentic & D. Stanfel

Authors
  1. L. Munjas Jurkic
    View author publications

    Search author on:PubMed Google Scholar

  2. M. Buratovic
    View author publications

    Search author on:PubMed Google Scholar

  3. I. Valentic
    View author publications

    Search author on:PubMed Google Scholar

  4. D. Stanfel
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to L. Munjas Jurkic.

Additional information

Published in the special paper collection 19th International Symposium on Separation Sciences with guest editors Tomislav Bolanča and Bogusław Buszewski.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Munjas Jurkic, L., Buratovic, M., Valentic, I. et al. UHPLC Study on the Degradation Profiles of Olopatadine Hydrochloride in Eye Drops Subjected to Heat and Filtration Methods of Sterilisation. Chromatographia 77, 1067–1080 (2014). https://doi.org/10.1007/s10337-014-2712-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-014-2712-y

Keywords